Latest Myocardial infarction Stories

IVUS data will evaluate plaque regression in patients with Coronary Artery Disease TSX Exchange Symbol: RVX CALGARY, Sept. 26, 2012 /PRNewswire/ - Resverlogix Corp. (TSX:RVX) today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial targeting high-risk cardiovascular disease patients. ASSURE will evaluate the ability of RVX-208, Resverlogix's BET protein inhibitor, to regress atherosclerotic disease versus placebo using intravascular ultrasound...

Striking findings highlight need for aggressive monitoring, early treatment to prevent later heart attacks, strokes A federally funded study led by researchers at Johns Hopkins Children's Center has found that children with mild to moderate kidney disease have abnormally thick neck arteries, a condition known as carotid atherosclerosis, usually seen in older adults with a long history of elevated cholesterol and untreated hypertension. The findings — published online ahead of print on...

Clinical Trial Findings Will Feature Research Breakthroughs in Interventional Cardiology NEW YORK, Sept. 14, 2012 /PRNewswire-USNewswire/ -- The Cardiovascular Research Foundation (CRF) has announced the late breaking trials and first report investigations that will be presented at next month's Transcatheter Cardiovascular Therapeutics (TCT) 2012 scientific symposium. TCT, the world's premier educational meeting specializing in interventional cardiovascular medicine, will take place...

WASHINGTON, Sept. 10, 2012 /PRNewswire/ -- September is Atrial Fibrillation Awareness Month, a time to raise awareness of a disease that affects over 5 million people in the United States, a number expected to rise to 12 million by 2050. Atrial Fibrillation (AFib) is an irregular, often rapid heart rate that prevents blood from effectively being pumped into the heart's ventricles. Symptoms of AFib can include heart palpitations, shortness of breath, chest pain and fatigue, but the...

The analysis of data from two Swedish registries was presented by Dr Anders Ulvenstam, and suggests that the reduction is due to improvements in AMI care. Ischemic stroke is a well known, relatively rare but potentially devastating complication following myocardial infarction. It can lead to severe neurological handicap and death for the patient and it is associated with great costs for society. "The risk of ischemic stroke after myocardial infarction has been studied previously, but...

Up to 400 cardiac events and 200 deaths in Swedish PCI patients could be avoided by following a heart healthy lifestyle, according to research from the SPICI study presented at ESC Congress 2012. The results were presented at ESC press conference by Professor Joep Perk from Linnaeus University and at the scientific session by Dr Roland CARLSSON. The benefits of adherence to a heart healthy lifestyle in combination with drug treatment after an acute myocardial infarction treated with...

Results of study from 16 hospitals in 8 countries to be presented at international meeting An ultra-fast, 320-detector computed tomography (CT) scanner can accurately sort out which people with chest pain need – or don't need – an invasive procedure such as cardiac angioplasty or bypass surgery to restore blood flow to the heart, according to an international study. Results of the study, which involved 381 patients at 16 hospitals in eight countries, are scheduled to be presented at...

For patients with stable coronary artery disease who have at least one narrowed blood vessel that compromises flow to the heart, medical therapy alone leads to a significantly higher risk of hospitalization and the urgent need for a coronary stent when compared with therapy that also includes initial placement of artery-opening stents. Those are the findings of a study to be published online Aug. 28 in the New England Journal of Medicine that was designed to evaluate the benefits of using...

WASHINGTON, Aug. 28, 2012 /PRNewswire/ -- The FAME 2 trial will improve treatment strategies for patients with stable ischemic heart disease. FAME 2 indicates that angioplasty and stenting (also known as percutaneous coronary intervention, or PCI) plus the best available medications results in better outcomes than medications alone for patients who have significant blockages in their heart arteries, as measured by a test known as Fractional Flow Reserve (FFR). With these results,...

MUNICH and WAYNE, N.J., Aug. 27, 2012 /PRNewswire/ -- MAQUET Cardiovascular LLC, the market leader in intra-aortic balloon counterpulsation therapy, today announced 30-day results from the large, randomized, multicenter IABP- SHOCK II ("SHOCK II") clinical trial in patients with acute myocardial infarction (AMI) who were in cardiogenic shock and undergoing early revascularization. The findings showed that use of intra-aortic balloon counterpulsation (IABC) therapy was associated with...